Case Studies

March, 2022
New insights to manage painful neuroma: Study of a nerve graft in rats

February, 2022
Tips for Choosing the Optimal Preclinical Model: Focus on Atherosclerosis and LDLR

January, 2022
Immunocompromised Human Serum Albumin/Human Neonatal Fc Receptor Mouse Model: A New Xenograft Model for Efficacy Studies of Immunotherapies

December, 2021
The Importance of Genetic Design When Choosing Your Preclinical Model: Focus on Preclinical Models for Cardiovascular Disorders — A Case Study on BMPR2

November, 2021
Predictive in vivo evaluation of immunotherapy efficacy: tHIS is a reliable model

September, 2021
When Rat Models Could Provide Optimized Translatability: The Case of CD89

September, 2021
The Importance of Genetic Design When Choosing Your Preclinical Model

September, 2021
Deciphering High-Dose IL-2 Toxicity in Reconstituted HIS Mice

April, 2021
Uncoupling Efficacy from Toxicity: A Case Study on MEDI5752

April, 2021
Uncoupling Toxicity from Therapeutic Efficacy: A Case Study on ATOR-1015